Cargando…

Manufacturing and Management of CAR T-Cell Therapy in “COVID-19’s Time”: Central Versus Point of Care Proposals

The COVID-19 pandemic, caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), has generated a significant repercussion on the administration of adoptive cell therapies, including chimeric antigen receptor (CAR) T-cells. The closing of borders, the reduction of people transit and the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ortiz de Landazuri, Iñaki, Egri, Natalia, Muñoz-Sánchez, Guillermo, Ortiz-Maldonado, Valentín, Bolaño, Victor, Guijarro, Carla, Pascal, Mariona, Juan, Manel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7593817/ https://www.ncbi.nlm.nih.gov/pubmed/33178200 http://dx.doi.org/10.3389/fimmu.2020.573179

Ejemplares similares

Practical aspects of chimeric antigen receptor T-cell administration: From commercial to point-of-care manufacturing
por: Martinez-Cibrian, Nuria, et al.
Publicado: (2022)

CAR-T after Stem Cell Transplantation in B-Cell Lymphoproliferative Disorders: Are They Really Autologous or Allogenic Cell Therapies?
por: Bartoló-Ibars, Ariadna, et al.
Publicado: (2021)

Inmunología en COVID-19; mucho más allá del diagnóstico de la infección o de la vacunación
por: Egri, Natalia, et al.
Publicado: (2022)

Immunology in COVID-19; more than diagnosis of infection or the basis of vaccination()
por: Egri, Natalia, et al.
Publicado: (2022)

Chemotherapy resistant Burkitt lymphoma: Possible novel therapies including CAR‐T cell infusion
por: Geerts, Paulus A. F., et al.
Publicado: (2023)

Working Algorithms and Detection Methods of Autoantibodies in Autoimmune Liver Disease: A Nationwide Study
por: Muñoz-Sánchez, Guillermo, et al.
Publicado: (2022)

Global Manufacturing of CAR T Cell Therapy
por: Levine, Bruce L., et al.
Publicado: (2016)

Point-Of-Care CAR T-Cell Production (ARI-0001) Using a Closed Semi-automatic Bioreactor: Experience From an Academic Phase I Clinical Trial
por: Castella, Maria, et al.
Publicado: (2020)

Impact of Manufacturing Procedures on CAR T Cell Functionality
por: Watanabe, Norihiro, et al.
Publicado: (2022)

Cellular and humoral responses after second and third SARS-CoV-2 vaccinations in patients with autoimmune diseases treated with rituximab: specific T cell immunity remains longer and plays a protective role against SARS-CoV-2 reinfections
por: Egri, Natalia, et al.
Publicado: (2023)

P1399: INITIAL CLINICAL RESULTS OF EUPLAGIA-1, A PHASE 1/2 TRIAL OF POINT-OF-CARE MANUFACTURED GLPG5201 IN R/R CLL/SLL WITH OR WITHOUT RICHTER’S TRANSFORMATION
por: Martinez-Cibrian, Nuria, et al.
Publicado: (2023)

CERN cars at car sharing point on the Meyrin site
por: Andrade, Rui
Publicado: (2022)

Spectrum of Disease Manifestations in Patients with Selective Immunoglobulin E Deficiency
por: Picado, César, et al.
Publicado: (2021)

Rapid manufacturing of non-activated potent CAR T cells
por: Ghassemi, Saba, et al.
Publicado: (2022)

Potential solutions for manufacture of CAR T cells in cancer immunotherapy
por: Blache, Ulrich, et al.
Publicado: (2022)

Anti-Phosphatidylserine/Prothrombin Antibodies at Two Points: Correlation With Lupus Anticoagulant and Thrombotic Risk
por: Egri, Natalia, et al.
Publicado: (2021)

IN VITRO ACTIVATION OF CELLULAR IMMUNE RESPONSE TO GROSS VIRUS-INDUCED LYMPHOMA
por: de Landazuri, Manuel Ortiz, et al.
Publicado: (1972)

Hot stamping advanced manufacturing technology of lightweight car body
por: Hu, Ping, et al.
Publicado: (2017)

Clinical manufacturing of CAR T cells: foundation of a promising therapy
por: Wang, Xiuyan, et al.
Publicado: (2016)

Optimization of metabolism to improve efficacy during CAR-T cell manufacturing
por: Zhang, Meng, et al.
Publicado: (2021)

Steering CAR T cell epigenetic programs by tweaking manufacturing protocol
por: Dukes, Meghan W., et al.
Publicado: (2023)

Characterization of Complex Concentrated Alloys and Their Potential in Car Brake Manufacturing
por: Anasiei, Ioana, et al.
Publicado: (2023)

Some Points in the Choice of a Car
Publicado: (1910)

863. ELISpot-BK virus assay for the assesment of BK virus cell-mediated immunity in kidney recipients
por: Herrera, Sabina, et al.
Publicado: (2023)

Unexpected Attraction of Polarotactic Water-Leaving Insects to Matt Black Car Surfaces: Mattness of Paintwork Cannot Eliminate the Polarized Light Pollution of Black Cars
por: Blaho, Miklos, et al.
Publicado: (2014)

Optimizing CAR-T Cell Manufacturing Processes during Pivotal Clinical Trials
por: Tyagarajan, Seshu, et al.
Publicado: (2019)

Large-scale manufacturing and characterization of CMV-CD19CAR T cells
por: Wang, Xiuli, et al.
Publicado: (2022)

Bioinstructive implantable scaffolds for rapid in vivo manufacture and release of CAR-T cells
por: Agarwalla, Pritha, et al.
Publicado: (2022)

CAR density influences antitumoral efficacy of BCMA CAR T cells and correlates with clinical outcome
por: Rodriguez-Marquez, Paula, et al.
Publicado: (2022)

Some Points in the Choice of a Car—II
Publicado: (1910)

Homology-independent targeted insertion (HITI) enables guided CAR knock-in and efficient clinical scale CAR-T cell manufacturing
por: Balke-Want, Hyatt, et al.
Publicado: (2023)

Revolutionizing car body manufacturing using a unified steel metallurgy concept
por: Lu, Qi, et al.
Publicado: (2021)

Chimeric Antigen Receptor T Cells Targeting CD19 and Ibrutinib for Chronic Lymphocytic Leukemia
por: Delgado, Julio, et al.
Publicado: (2019)

Physiological lentiviral vectors for the generation of improved CAR-T cells
por: Tristán-Manzano, María, et al.
Publicado: (2022)

Physiological lentiviral vectors for the generation of improved CAR-T cells
por: Tristán-Manzano, María, et al.
Publicado: (2022)

Cellular and humoral immune response after mRNA-1273 SARS-CoV-2 vaccine in liver and heart transplant recipients
por: Herrera, Sabina, et al.
Publicado: (2021)

P1394: RITUXIMAB BASED LYMPHODEPLETION MAY INCREASE ENGRAFTMENT AND EFFICACY OF SECOND INFUSIONS OF CART19 CELLS IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA.
por: Ortiz-Maldonado, Valentín, et al.
Publicado: (2023)

The effect of sleep disorder on the work ability of workers in a car accessories manufacturing plant
por: Labbafinejad, Yasser, et al.
Publicado: (2014)

Automated Manufacture of Autologous CD19 CAR-T Cells for Treatment of Non-hodgkin Lymphoma
por: Jackson, Zachary, et al.
Publicado: (2020)

CAR-T manufactured from frozen PBMC yield efficient function with prolonged in vitro production
por: Abraham-Miranda, Julieta, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_h67chhgrk7upik9tatuec95ull